Oncology Sequencing Market Size & Trends 
                     Oncology Sequencing Market Size & Trends 
According to a new market research report published by Global Market Estimates, the Global Oncology
Sequencing Market is projected to grow at a CAGR of 13.5% from 2022 to 2027. 
Thermo Fisher Scientific, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd., QIAGEN, BGI, Agilent 
Technologies, Guardant Health, Biocept, Inc., Myriad Genetics, Inc., and eviCore healthcare among others,
are some key players in the oncology sequencing market.
Browse 151 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC on
“Global  Oncology  Sequencing  Market -  Forecast  to  2027’’
https://www.globalmarketestimates.com/market-report/oncology-sequencing-market-3892
 
By  Technology  (Whole-Genome  Sequencing,  Exome  Sequencing,  Targeted  Sequencing,  RNA
Sequencing),  By Product  (Instruments  & Platforms,  Reagents  & Other  Consumables),  By Application
(Clinical and Research), By Indication (Breast Cancer, Ovarian Cancer, Prostate Cancer, Lung Cancer,
Colorectal  Cancer, Melanoma, Cervical Cancer, Others), By End-use (Pharmaceutical & Biotechnology
Company, Academic & Government Research Institutes, and Others), By Region (North America, Asia
Pacific, Central & South America, Europe, and the Middle East & Africa), End-User Landscape Analysis,
Company Market Share Analysis, and Competitor Analysis
Technology Outlook (Revenue, USD Million, 2022-2027)
 Whole-Genome Sequencing
 Exome Sequencing
 Targeted Sequencing
 RNA Sequencing
Application Outlook (Revenue, USD Million, 2022-2027)
 Clinical
 Research
Product Outlook (Revenue, USD Million, 2022-2027)
 Instruments & Platforms
 Reagents & Other Consumables
End-use Outlook (Revenue, USD Million, 2022-2027)
 Pharmaceutical & Biotechnology Company
 Academic & Government Research Institutes
 Others
Indication Outlook (Revenue, USD Million, 2022-2027)
 Breast Cancer
 Ovarian Cancer
 Prostate Cancer
 Lung Cancer
 Colorectal Cancer
 Melanoma
 Cervical Cancer
 Others
Regional Outlook (Revenue, USD Million, 2022-2027)
North America
 The U.S.
 Canada
 Mexico
Europe
 Germany
 UK
 France
 Spain
 Italy
 Rest of Europe
Asia Pacific
 China
 India
 Japan
 South Korea
 Rest of APAC
Central & South America
 Brazil
 Rest of CSA
Middle East & Africa
 Saudi Arabia
 South Africa
 Rest of MEA
Contact: Yash Jain
Email address: [email protected]
Phone Number: +1 6026667238